Behavioral Health Collaborative Care Model in an ICU Recovery Clinic (BeColM)
Status
Conditions
Treatments
Details and patient eligibility
About
Survivors of critical illness are at high risk for mental health issues such as anxiety, depression, and PTSD. This single-site, randomized controlled trial at the Medical University of South Carolina will enroll 150 patients to compare outcomes between a behavioral health Collaborative Care Model (BH CoCM) and usual care (attention control). The intervention includes digital tools (Neuroflow), behavioral health coaching, and psychiatric support.
Full description
Patients seen in the MUSC ICU Recovery Clinic will be approached for consent for enrollment. Patients that consent will be randomized to an attention control group or an intervention group.
The intervention group receive BH CoCM. They will have access to NeuroFlow platform, which has been specifically designed to support delivery of a BH CoCM. They will utilize Neuroflow for 6 months. They will undergo assessments for anxiety, depression, post-traumatic stress. A behavioral manager will monitor their needs and provide behavioral health coaching and psychiatric support as needed.
The attention control group will undergo assessments for anxiety, depression, post-traumatic stress.
Investigators will look at changes over six months in intervention group compared to attention control group for patients in terms of symptoms of depression, anxiety, post-traumatic stress. Investigators will also look at adherence, BH CoCM implementation metrics, type and amount of guided content accessed in NeuroFlow. Investigators will perform qualitative surveys to understand better what patients thought about the intervention and ways in which it could be improved.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Attendance at the MUSC ICU Recovery Clinic within 180 days of discharge from the hospital
Exclusion criteria
- ICU Admission was due to a primary addiction diagnosis (eg alcohol withdrawal or delirium tremens requiring ICU care)
- Serious Mental Illness such as Schizophrenia, psychotic disorder, acute mania
- Late Stage Dementia or Cognitive Impairment
- Limited English or Spanish Proficiency
- Lack of regular access to a computer, tablet or mobile device with internet access
Trial design
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Rita Bakhru, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal